Biomarkers in diabetic kidney disease: good use and pitfalls

Biomarkers in diabetic kidney disease: good use and pitfalls

Bibliographic Details
Main Author:	Silvia Titan
Format:	Article
Language:	English
Published:	Brazilian Society of Endocrinology and Metabolism
Series:	Archives of Endocrinology and Metabolism
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972016000200092&lng=en&tlng=en

Similar Items

Advantages and Pitfalls in Fluid Biomarkers for Diagnosis of Alzheimer’s Disease
by: Syed Haris Omar, et al.
Published: (2020-07-01)

Myocardial Ischemia Assessment in Chronic Kidney Disease: Challenges and Pitfalls
by: Susie Fei Cen Parnham, et al.
Published: (2014-12-01)

Is Making Good Use of Behavioral Pitfalls Helpful for the Quality of Dividend Decisions?
by: WANG,JIA-LING, et al.
Published: (2018)

Formulating a good research question: Pearls and pitfalls
by: Wilson Fandino
Published: (2019-01-01)

Potential predictive biomarkers for early detection of diabetic kidney disease
by: M.S. Hussain, et al.
Published: (2020-12-01)

Diabetic kidney disease: An overview of prevalence, risk factors, and biomarkers
by: Salman Hussain, et al.
Published: (2021-01-01)

Tripping the traps and pitfalls of community-initiated conservation using good collaborative principles
by: Walls, Timothy Stuart
Published: (2009)

Tripping the traps and pitfalls of community-initiated conservation using good collaborative principles
by: Walls, Timothy Stuart
Published: (2009)

AI for the Common Good?! Pitfalls, challenges, and ethics pen-testing
by: Berendt Bettina
Published: (2019-01-01)

Chemerin: A biomarker for cardiovascular disease in diabetic chronic kidney disease patients
by: Farag E Salama, et al.
Published: (2016-01-01)

Circulating kidney injury molecule‐1 as a biomarker of renal parameters in diabetic kidney disease
by: Tomohito Gohda, et al.
Published: (2020-03-01)

Non-Coding RNAs as Biomarkers and Therapeutic Targets for Diabetic Kidney Disease
by: Yue-Yu Gu, et al.
Published: (2021-01-01)

Pitfall in the Diagnosis of Diabetes Insipidus and Pregnancy
by: Melissa Sum, et al.
Published: (2017-01-01)

Management of diabetes mellitus in individuals with chronic kidney disease: therapeutic perspectives and glycemic control
by: Carolina C.R. Betônico, et al.
Published: (2016-01-01)

How not to think about biomarkers in psychiatry: Challenges and conceptual pitfalls
by: Awais Aftab, et al.
Published: (2021-06-01)

The world of targeted therapies in kidney cancers: pitfalls, tips and tricks
by: Vallard A, et al.
Published: (2017-03-01)

Alpha-Synuclein as a Biomarker of Parkinson’s Disease: Good, but Not Good Enough
by: Upasana Ganguly, et al.
Published: (2021-07-01)

Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol
by: Kim M. Gooding, et al.
Published: (2020-06-01)

MicroRNA as novel biomarkers and therapeutic targets in diabetic kidney disease: An update
by: Qinghua Cao, et al.
Published: (2019-06-01)

MicroRNAs: new biomarkers and promising therapeutic targets for diabetic kidney disease
by: Linicene Rosa do Nascimento, et al.
Published: (2019-02-01)

Kawasaki disease epidemic: pitfalls
by: Romina Gallizzi, et al.
Published: (2020-08-01)

Genetics of Type 2 Diabetes—Pitfalls and Possibilities
by: Rashmi B. Prasad, et al.
Published: (2015-03-01)

Candidate Glaucoma Biomarkers: From Proteins to Metabolites, and the Pitfalls to Clinical Applications
by: Andrés Fernández-Vega Cueto, et al.
Published: (2021-08-01)

Interpretation of Autosomal Recessive Kidney Diseases With “Presumed Homozygous” Pathogenic Variants Should Consider Technical Pitfalls
by: Haiyue Deng, et al.
Published: (2020-04-01)

Endoplasmic Reticulum Stress in the Diabetic Kidney, the Good, the Bad and the Ugly
by: Robyn Cunard
Published: (2015-04-01)

Comparison of Circulating Biomarkers in Predicting Diabetic Kidney Disease Progression With Autoantibodies to Erythropoietin Receptor
by: Megumi Oshima, et al.
Published: (2021-02-01)

Urinary Microvesicle-Bound Uromodulin: A Potential Molecular Biomarker in Diabetic Kidney Disease
by: Neng-jun Lou, et al.
Published: (2017-01-01)

Cardiovascular biomarkers in chronic kidney disease
by: Đerić Mirjana, et al.
Published: (2010-01-01)

Dimethylarginine: Biomarkers in progression of kidney disease
by: Cvetković Tatjana, et al.
Published: (2012-01-01)

Chronic kidney disease in children: Using novel biomarkers as predictors of disease
by: Samuel N Uwaezuoke, et al.
Published: (2018-01-01)

Usability Pitfalls of Diabetes mHealth Apps for the Elderly
by: Maša Isaković, et al.
Published: (2016-01-01)

Radical Cystectomy and Lymphadenectomy to Two Patients with Pelvic Kidney: Surgical Pitfalls and Considerations
by: I. Adamakis, et al.
Published: (2013-01-01)

Potential for Novel Biomarkers in Diabetes-Associated Chronic Kidney Disease: Epigenome, Metabolome, and Gut Microbiome
by: Ashani Lecamwasam, et al.
Published: (2020-09-01)

Urinary Exosomal MiRNA-4534 as a Novel Diagnostic Biomarker for Diabetic Kidney Disease
by: Yanyan Zhao, et al.
Published: (2020-08-01)

Neutrophil Gelatinase-Associated Lipocalin and Retinol-Binding Protein-4 as Biomarkers for Diabetic Kidney Disease
by: Fatemeh Abbasi, et al.
Published: (2020-01-01)

Evaluation of urinary biomarkers for prediction of diabetic kidney disease: a propensity score matching analysis
by: Yongzhang Qin, et al.
Published: (2019-11-01)

Circulating Tumor Necrosis Factor Receptors: A Potential Biomarker for the Progression of Diabetic Kidney Disease
by: Maki Murakoshi, et al.
Published: (2020-03-01)

Comprehensive mass spectrometry based biomarker discovery and validation platform as applied to diabetic kidney disease
by: Scott D. Bringans, et al.
Published: (2017-03-01)

Urine NGAL as an early biomarker for diabetic kidney disease: accumulated evidence from observational studies
by: Xing-Yao Tang, et al.
Published: (2019-01-01)

Pitfalls of Using Biomarker Maturity Parameters for Organic Matter Maturity Assessment Suggested by Coal Hydrous Pyrolysis
by: Huang, H., et al.
Published: (2022)